BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, this week presented new biomarker data from the Phase...
Company Provides Alzheimer’s Disease Patients Greater Access to Care through Administration of LEQEMBI In-home or On-site at its Infusion Centers
Soleo Health, an innovative leader and...
The US Food and Drug Administration (FDA) converted the approval process for Leqembi ( lecanemab-irmb), indicated for the treatment of adult patients with Alzheimer's...
InsideTracker caps off its rapid 60-day product evolution with the addition of insulin testing. InsideTracker's comprehensive health analysis now includes up to 48 biomarkers,...
Serving thousands of patients annually, MedPeds streamlines operations and improves care offerings
eClinicalWorks, the largest ambulatory cloud EHR, announced the recent successes of its partnership...
